MiraVista Diagnostics’ dedication to innovation and improved accessibility to high quality fungal diagnostics has created a CE marked Histoplasma Urine Antigen LFA.

MiraVista Diagnostics is leading the industry with a new Histoplasma Urine Antigen LFA. The rapid, non-invasive test has a proven clinical sensitivity of 93.18% and 96.97% specificity relative to culture proven cases, can be operated in low complexity clinical settings and requires no additional equipment.

Review our May 26th, 2020 Press Release regarding this new announcement


Key Benefits and Features

40-minute turnaround time
CE-marked product
Accurate, visually detectable results
Non-invasive specimen collection
25 test per kit

Rapid diagnosis can help treatment begin more quickly, reduce duration of anti-fungal therapy and help the patient recover faster.

The Process
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo